By: Sabiha Toni
Alternative medicine and therapy has always been a controversial field in science, often because there is no conclusive evidence supporting many of the options offered. The legitimacy of alternative treatments are still argued by scientists and doctors—while some are in support of certain therapies, others find no reason to accept them. Patients, parents, or relatives swear by them from personal experience, or others’ experiences. The same is applicable for ASD treatments. Hypotheses are proposed and experimented to explain autism’s unclear mechanism in the brain and its complex set of causes. In the process, novel treatments are developed based on these theories, even before convincing evidence has been shown of their validity.
One such theory is the Opioid Excess Theory, which attempts to explain the physiological mechanism of autistic behavior. It proposes that certain proteins from diets are broken down incorrectly in the body and reabsorbed by an abnormally permeable gut. Some of these byproducts cross through the blood-brain barrier and act as opiates (Shattock, Whiteley, 2002). Further studies show the correlation between this improper metabolism and certain autistic behaviors in rat models (Sun, Cade, 1999). These opiate-like peptides can be derived from two proteins called casein and gluten, which are found in common foods such as wheat bread or milk.
Thus, a dietary option called gluten-free, casein-free diet (GFCF diet) was offered as a treatment plan. Foods that contain gluten, such as wheat, rye, barley and oats, and those that have casein (most dairy products) are excluded from an autistic individual’s diet. If the Opioid Excess Theory is valid, by eliminating dietary intake of proteins that act as opiates in the brain, one can expect certain signs of autism to lessen over time.
Though the GFCF diet is sometimes recommended as a treatment approach to ASDs, there is controversy surrounding the effectiveness of the treatment. While experiments show that GFCF diet may in fact be helpful for an autistic individual, others show no significant findings. Scientific articles that evaluate research done about the effectiveness of GFCF found conflicting data on the subject (Mulloy et al., 2009). Since it is difficult to reproduce results for the GFCF diet, the evidence remains inconclusive.
However, many parents and relatives feel that every approach should be taken advantage of, especially if it is as simple as changing a diet. Research suggests that constricting an individual’s diet to gluten-free and casein-free products may contribute to nutritional deficiencies in children (Mulloy et al., 2009). Children with autism who were subjected to GFCF diets were shown to have deficient amounts of essential amino acids than those who were not on a restricted diet (Arnold, Hyman, Mooney, Kirby, 2009).
Gluten-free, casein-free diets have risen in popularity among individuals with autism because of the convenience of such a treatment approach. Although there is some scientific basis to alternative treatments, it is important to keep in mind that the effectiveness of restricted diets has not been established in ASD patients. It is also essential to consider the health risks associated with such treatments, which may hinder development in younger autistic individuals. These options are available, however, and may even prove effective with further research.
Arnold, G., Hyman, S., Mooney, R., & Kirby, R. Plasma amino acids proﬁles in children with autism: Potential risk of nutritional deﬁciencies. Journal of Autism and Developmental Disorders. 2003; 33(4): 449–454.
Millward, C., Ferriter, M., Calver, S., Connell-Jones, G. Gluten- and casein-free diets for autistic spectrum disorder. Cochrane Database System Rev. 2008; (2).
Mulloy, A., Lang, R., O’Reilly, M., Sigafoos, J., Lancioni, G., Rispoli, M. Gluten-free and casin-free diets in the treatment of autism spectrum disorders: A systematic review. Research in Autism Spectrum Disorders 2010; 4(3): 328-339.
Shattock, P., Whiteley, P. Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention. Expert Opin. Ther. Targets. 2002; 6(2): 175-83.